Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
Final published version, 682 KB, PDF document
| Original language | English |
|---|---|
| Journal | American Journal of Medical Genetics. Part A |
| Volume | 179 |
| Issue number | 6 |
| Pages (from-to) | 1069-1073 |
| Number of pages | 5 |
| ISSN | 1552-4825 |
| DOIs | |
| Publication status | Published - 2019 |
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 224702411